These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23493410)

  • 1. Association between frequent cardiac resynchronization therapy optimization and long-term clinical response: a post hoc analysis of the Clinical Evaluation on Advanced Resynchronization (CLEAR) pilot study.
    Delnoy PP; Ritter P; Naegele H; Orazi S; Szwed H; Zupan I; Goscinska-Bis K; Anselme F; Martino M; Padeletti L
    Europace; 2013 Aug; 15(8):1174-81. PubMed ID: 23493410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
    Brenyo A; Kutyifa V; Moss AJ; Mathias A; Barsheshet A; Pouleur AC; Knappe D; McNitt S; Polonsky B; Huang DT; Solomon SD; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Aug; 10(8):1136-43. PubMed ID: 23712031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cardiac resynchronization therapy optimization inside a heart failure programme: a real-world experience.
    Moulin T; Hamon D; Djouadi K; D'Humières T; Elbaz N; Boukantar M; Zerbib C; Rouffiac S; Dhanjal TS; Ernande L; Derumeaux G; Teiger E; Damy T; Lellouche N
    ESC Heart Fail; 2022 Oct; 9(5):3101-3112. PubMed ID: 35748123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods.
    Ritter P; Delnoy PP; Padeletti L; Lunati M; Naegele H; Borri-Brunetto A; Silvestre J
    Europace; 2012 Sep; 14(9):1324-33. PubMed ID: 22549295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential benefit of optimizing atrioventricular & interventricular delays in patients with cardiac resynchronization therapy.
    Urbanek B; Kaczmarek K; Klimczak A; Ruta J; Chudzik M; Piestrzeniewicz K; Ptaszynski P; Wranicz JK
    Indian J Med Res; 2017 Jul; 146(1):71-77. PubMed ID: 29168462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of Left Ventricular Remodeling and Regional Dyssynchrony on Long-Term Prognosis after Cardiac Resynchronization Therapy.
    Tayal B; Sogaard P; Delgado-Montero A; Goda A; Saba S; Risum N; Gorcsan J
    J Am Soc Echocardiogr; 2017 Mar; 30(3):244-250. PubMed ID: 27986357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
    Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
    Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Effect of Different Optimizing Methods for Cardiac Resynchronization Therapy in Patients with Heart Failure: A Randomized and Controlled Pilot Study.
    Zhang Y; Xing Q; Zhang JH; Jiang WF; Qin M; Liu X
    Cardiology; 2019; 142(3):158-166. PubMed ID: 31189165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of atrioventricular conduction delay on the outcome of cardiac resynchronization therapy.
    Lee YH; Wu JH; Asirvatham SJ; Del Carpio Munoz F; Webster T; Brooke KL; Hodge DO; Wiste HJ; Friedman PA; Cha YM
    J Electrocardiol; 2014; 47(6):930-5. PubMed ID: 25169796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal variation in optimal atrioventricular and interventricular delay during cardiac resynchronization therapy.
    Porciani MC; Dondina C; Macioce R; Demarchi G; Cappelli F; Lilli A; Pappone A; Ricciardi G; Colombo PC; Padeletti M; Jelic S; Padeletti L
    J Card Fail; 2006 Dec; 12(9):715-9. PubMed ID: 17174233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female gender is associated with a better outcome after cardiac resynchronization therapy.
    Leyva F; Foley PW; Chalil S; Irwin N; Smith RE
    Pacing Clin Electrophysiol; 2011 Jan; 34(1):82-8. PubMed ID: 21214589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrically vs. imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.
    Stephansen C; Sommer A; Kronborg MB; Jensen JM; Nørgaard BL; Gerdes C; Kristensen J; Jensen HK; Fyenbo DB; Bouchelouche K; Nielsen JC
    Europace; 2019 Sep; 21(9):1369-1377. PubMed ID: 31274152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, echocardiographic, and neurohormonal response to cardiac resynchronization therapy: are they interchangeable?
    Hoogslag GE; Höke U; Thijssen J; Auger D; Marsan NA; Wolterbeek R; Holman ER; Schalij MJ; Bax JJ; Verwey HF; Delgado V
    Pacing Clin Electrophysiol; 2013 Nov; 36(11):1391-401. PubMed ID: 23826659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term effects of cardiac resynchronization therapy in non-ambulatory NYHA IV heart failure patients.
    Theodorakis G; Katsikis A; Livanis E; Kostopoulou A; Adamopoulos S; Tsiapras D; Voudris V
    Pacing Clin Electrophysiol; 2011 Nov; 34(11):1553-60. PubMed ID: 21913946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up after cardiac resynchronization therapy-optimization in a real-world setting: A single-center cohort study.
    Korach R; Kahr PC; Ruschitzka F; Steffel J; Flammer AJ; Winnik S
    Cardiol J; 2021; 28(5):728-737. PubMed ID: 31960943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mid-term outcomes in patients implanted with cardiac resynchronization therapy.
    Lee SH; Park SJ; Kim JS; Shin DH; Cho DK; On YK
    J Korean Med Sci; 2014 Dec; 29(12):1651-7. PubMed ID: 25469065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional echocardiographic optimization improves outcome in cardiac resynchronization therapy compared to ECG optimization: a randomized comparison.
    Sonne C; Bott-Flugel L; Hauck S; Hadamitzky M; Lesevic H; Demetz G; Braun D; Wolf P; Hausleiter J; Schömig A; Kolb C
    Pacing Clin Electrophysiol; 2014 Mar; 37(3):312-20. PubMed ID: 24164640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.
    Schuchert A; Muto C; Maounis T; Frank R; Boulogne E; Polauck A; Padeletti L;
    Europace; 2013 Jan; 15(1):71-6. PubMed ID: 22927665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multipoint left ventricular pacing improves response to cardiac resynchronization therapy with and without pressure-volume loop optimization: comparison of the long-term efficacy of two different programming strategies.
    Ciconte G; Ćalović Ž; McSpadden LC; Ryu K; Mangual J; Caporaso I; Baldi M; Saviano M; Cuko A; Vitale R; Conti M; Giannelli L; Vicedomini G; Santinelli V; Pappone C
    J Interv Card Electrophysiol; 2019 Mar; 54(2):141-149. PubMed ID: 30483980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients' age.
    Brambatti M; Guerra F; Matassini MV; Cipolletta L; Barbarossa A; Urbinati A; Marchesini M; Capucci A
    Europace; 2013 May; 15(5):704-10. PubMed ID: 23385052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.